ArticleBMC genomics2021
GEP-EpiSeeker: a gene expression programming-based method for epistatic interaction detection in genome-wide association studies.
Article in BMC genomics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- SEEI: spherical evolution with feedback mechanism for identifying epistatic interactions.BMC genomics · 2024Article
- Classifying breast cancer subtypes on multi-omics data via sparse canonical correlation analysis and deep learning.BMC bioinformatics · 2024Article
- Exploring gene-patient association to identify personalized cancer driver genes by linear neighborhood propagation.BMC bioinformatics · 2024Article
- Gender specific SNP markers in Coscinium fenestratum (Gaertn.) Colebr. for resource augmentation.Molecular biology reports · 2024Article
- STS-BN: An efficient Bayesian network method for detecting causal SNPs.Frontiers in genetics · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIdentification of epistatic interactions provides a systematic way for exploring associations among different single nucleotide polymorphism (SNP) and complex diseases. Although considerable progress has been made in epistasis detection, efficiently and accurately identifying epistatic interactions remains a challenge due to the intensive growth of measuring SNP combinations.
resultsIn this work, we formulate the detection of epistatic interactions by a combinational optimization problem, and propose a novel evolutionary-based framework, called GEP-EpiSeeker, to detect epistatic interactions using Gene Expression Programming. In GEP-EpiSeeker, we propose several tailor-made chromosome rules to describe SNP combinations, and incorporate Bayesian network-based fitness evaluation into the evolution of tailor-made chromosomes to find suspected SNP combinations, and adopt the Chi-square test to identify optimal solutions from suspected SNP combinations. Moreover, to improve the convergence and accuracy of the algorithm, we design two genetic operators with multiple and adjacent mutations and an adaptive genetic manipulation method with fuzzy control to efficiently manipulate the evolution of tailor-made chromosomes. We compared GEP-EpiSeeker with state-of-the-art methods including BEAM, BOOST, AntEpiSeeker, MACOED, and EACO in terms of power, recall, precision and F1-score on the GWAS datasets of 12 DME disease models and 10 DNME disease models. Our experimental results show that GEP-EpiSeeker outperforms comparative methods.
conclusionsHere we presented a novel method named GEP-EpiSeeker, based on the Gene Expression Programming algorithm, to identify epistatic interactions in Genome-wide Association Studies. The results indicate that GEP-EpiSeeker could be a promising alternative to the existing methods in epistasis detection and will provide a new way for accurately identifying epistasis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.